PROTEOME SCIENCES PLC Logo

PROTEOME SCIENCES PLC

PRM | IL

Overview

Corporate Details

ISIN(s):
GB0003104196
LEI:
213800Q62ICXANKU2986
Country:
United Kingdom
Address:
COVEHAM HOUSE, KT11 3EP COBHAM
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Proteome Sciences PLC is a specialist Contract Research Organisation (CRO) providing outsourced proteomics services to support drug discovery, development, and biomarker identification. The company offers a full suite of mass spectrometry-based protein discovery and detection tools, handling diverse biological samples for a global client base of biopharmaceutical organizations. A key innovator, Proteome Sciences invented, developed, and exclusively manufactures the TMT® and TMTpro® isobaric tags for protein quantification, which are distributed globally through Thermo Fisher Scientific. Its end-to-end services, from sample preparation to bioinformatics and reporting, operate under ISO 9001:2015 and Good Clinical Laboratory Practice (GCLP) standards.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for PROTEOME SCIENCES PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-05-16 14:17
Post-Annual General Meeting Information
Result of AGM
English 10.7 KB
2025-02-21 08:00
Regulatory News Service
Contract Win
English 12.5 KB
2024-12-23 08:08
Capital/Financing Update
Loan Facility, Trading Update & Directorate Change
English 17.8 KB
2024-09-13 08:00
Earnings Release
Interim Results and Directorate Change
English 183.4 KB
2024-05-16 14:10
Post-Annual General Meeting Information
Result of AGM
English 10.5 KB
2024-05-16 08:00
Post-Annual General Meeting Information
AGM Statement
English 11.9 KB
2024-04-26 08:00
Regulatory News Service
Contract Win
English 12.3 KB
2024-04-10 08:00
Earnings Release
Final Results
English 231.2 KB
2024-01-02 08:00
Regulatory News Service
Completion of new facility in San Diego
English 12.3 KB
2023-11-30 08:00
Earnings Release
Trading Update
English 12.8 KB
2023-10-02 08:00
Investor Presentation
Launch of Single Cell Proteomics Services
English 12.7 KB
2023-08-30 15:14
Report Publication Announcement
Investor Presentation
English 11.5 KB
2023-08-25 08:00
Earnings Release
Interim Results
English 186.0 KB
2023-06-01 10:43
Capital/Financing Update
Repayment of Loan
English 9.8 KB
2023-05-17 14:05
Post-Annual General Meeting Information
Result of AGM
English 9.6 KB

Automate Your Workflow. Get a real-time feed of all PROTEOME SCIENCES PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for PROTEOME SCIENCES PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN